Coverage
Filings
Orion's collaboration partner Bayer announced U.S. FDA approval for darolutamide, an androgen receptor inhibitor (ARi), for metastatic hormone-sensitive prostate cancer (mHSPC).
| 19 Nov 2008 |
| Orion sues Sun Pharma Global, Inc. in the U.S. to enforce Orion's U.S. Patent No. 5,446,194 covering its proprietary drug Comtan® | 12 Nov 2008 |
| Orion comments on ANDA filed by Wockhardt Limited for a generic version of Orion's proprietary drug Stalevo® in the United States | 3 Nov 2008 |
| Composition of the Nomination Committee of Orion Corporation | 29 Oct 2008 |
| Orion Group Interim Report 1-9/2008 | 28 Oct 2008 |
| Orion Corporation's publication schedules for financial reporting in 2009 | 28 Oct 2008 |